Ayurvedic management of Chirakari Vicharchika (Eczema) : A Case Report

Skin is the largest organ of the body that constitutes the first line of defence and hence is first to be exposed to disease. Among them eczema is one of the most common clinical presentations. With an incidence of 2 -3 % of all medical problems and about 30 percent of all the dermatitis. Eczema is a non-contagious inflammation of the skin, characterised by erythema, scaling, oedema, vesiculation and oozing. In Ayurveda it is correlated with Vicharchika because of similar features like Kandu, Srava, Pidaka. Vicharchika is considered as Kshudra Kushta.[1] In the contemporary science there is no satisfactory treatment available with a lot of side effects and increased rate of recurrence. The unique line of management in Ayurveda helps in removing disease right from its root. Here is a case of Vicharchika (eczema) treated with this thinking to highlight treatment principles

CROSS SECTIONAL SURVEY TO ASSESS THE BENEFICIARIES EXPERIENCE REGARDING COVID -19 VACCINATION IN VACCINATED CANDIDATES IN A TRIBAL DISTRICT OF RAJASTHAN - EMIGH PROSPECTIVE

ABSTRACT-BACKGROUND-A year with covid-19 has been a harrowing breakneck journey. On 11th March-2020 WHO declared COVID-19 as a pandemic. It spread across globe in span of 3 months, this is how emergence of unknown virus became a multifaceted pandemic. Till date no definitive treatment of covid-19 is available, except hope of vaccination. We must ensure safe and effective vaccination to protect people. It’s been largest vaccination drive, that’s why important to know the beneficiary’s point of view regarding covid vaccination process. So that the result of this study can be used to amend the process if needed, to make the process more beneficiary friendly. Method-Cross sectional study was conducted in a government covid vaccination centerto assess the beneficiaries prospective about their experience of covid-19 vaccine. Study duration was 6 months. Data was collected with the help of semi-structured proforma. Results-Data analysis was done with the help of SPSS-20. Approximately 93% of participants received vaccination appointment. Around 58% participants were screened for covid-19 symptoms. Most (90%) participants said that physical distancing was maintained during vaccination, 93% participants were informed about of vaccination process, 85% participant mentioned that Staff had explained about AEFI before vaccination and 76% participants mentioned that they received Covishied, only 1 participant reported AEFI within 30 mins of waiting period and he received the preliminary treatment at vaccination center. Conclusion-feedback from the user is a good way to quality check, their reviews give the opportunity to improve. Most of the vaccines were satisfied with the vaccination procedure

Global polarization of Λ and Λ hyperons in Pb-Pb collisions at √ s N N = 2.76 and 5.02 TeV

The global polarization of Λ and Λ hyperons is measured for Pb-Pb collisions at √sNN = 2.76 and 5.02 TeV recorded with the ALICE at the Large Hadron Collider (LHC). The results are reported differentially as a function of collision centrality and hyperon’s transverse momentum (pT ) for the range of centrality 5–50%, 0.5 < pT < 5 GeV/c, and rapidity |y| < 0.5. The hyperon global polarization averaged for Pb-Pb collisions at √sNN = 2.76 and 5.02 TeV is found to be consistent with zero, ⟨PH⟩(%)≈0.01±0.06(stat.)±0.03(syst.) in the collision centrality range 15–50%, where the largest signal is expected. The results are compatible with expectations based on an extrapolation from measurements at lower collision energies at the Relativistic Heavy Ion Collider, hydrodynamical model calculations, and empirical estimates based on collision energy dependence of directed flow, all of which predict the global polarization values at LHC energies of the order of 0.01%